Skip to main content

Table 2 Demographics of drug-naïve epileptic patient according to the serum concentration of GluR3B antibodies. Notes: serum concentration of GluR3B antibodies: group A ≥ 0.335 OD; group B < 0.335 OD

From: The correlation of GluR3B antibody with T lymphocyte subsets and inflammatory factors and their role in the progression of epilepsy

 

Drug-naïve patients (n = 66)

Group A (n = 9)

Group B (n = 57)

P

Age (years)

41.1 ± 25.0

36.7 ± 21.0

0.43

Gender (M,%)

4.0 (44.4)

33.0 (57.9)

0.45

Epilepsy duration, y

[M (P25,P75)]

0.01 (0.01, 0.7)

0.3 (0.03, 2.0)

0.079

Age at first seizure, y

[M (P25,P75)]

51.0 (15.0, 61.0)

33.0 (15.0, 52.0)

0.51

Abnormal EEG (n, %)

8.0 (88.9)

43.0 (75.4)

0.37

Abnormal MRI (n, %)

4.0 (44.4)

18.0 (31.6)

0.45

Number of AEDs

-

-

-